Г.Баясгалан
Loading...
Товч нэр
Г.Баясгалан
Бүтэн нэр
Гомбожав Баясгалан
Латин нэр
Gombojav Bayasgalan
Албан тушаал
Ахлах багш
Харьяалал
Scopus Author ID
2 results
Now showing 1 - 2 of 2
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Current Situation of Anemia Management among Hemodialysis Patients in Mongolia(Mongolian National University of Medical Sciences, 2020-04-01); ; ;Khurtsbayar Damdinsuren; Dulguun BuyanjargalObjectives: The purpose of our study was to determine the current practice of anemia management prevalent among hemodialysis patients in Mongolia. Furthermore, we assessed the appropriateness of anemia management by comparing the observed practice to evidence-based clinical guidelines. Methods: A survey was conducted on 132 patients undergoing hemodialysis in State First Hospital, State Third Hospital, ICU Dialysis Center, and Intermed Hospital. All patients who were over 18 years of age with ESRD undergoing hemodialysis were included. Patients were excluded if they had cancer, were receiving chemotherapy or radiotherapy, or undergoing dialysis less than three times per week. Data on anemia parameters, erythropoietin dosing, iron supplementation, in addition to demographic data, were collected. The data were collected over a one year retrospectively from January 1 to December 31, 2018. Patients were assessed according to a pre-specified protocol. Results: Data were collected from 132 patients. The mean Hgb value for those patients was 10.31 ± 1.59 g/dL. Seventy-four patients (56.1%) had mean Hgb values between 9.5 and 11.5 g/dL, the target range recommended by KDIGO guidelines. The mean weekly prescribed dose of erythropoietin was 3825 ± 5054 IU/week (57 ± 72 IU/kg/week). Information on ferritin concentrations was available for 32 (24.2%) patients. The median serum ferritin concentration for those patients was 95.41 ng/mL (IQR=40.83 - 259.27). None of the patients had transferrin saturation (TSAT) values recorded. Conclusion: There is an opportunity to improve anemia management in hemodialysis patients in Mongolia through the evaluation of secondary causes of low response to erythropoietin and better monitoring and management of iron status. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Biochemical and Hematological Patterns of Hospitalized COVID-19 Patients in Mongolia(Mongolian National University of Medical Sciences, 2023-11-06); ; ; Objectives: The impact of COVID-19 prompted a race to find a treatment that would reduce its mortality. This study aimed to analyze how the clinical and laboratory characteristics reflect the disease process and progression of COVID-19 cases in hospitalized patients of Mongolia, which could be informative in managing patients with COVID-19. Methods: A cross-sectional study was conducted on the prescription patterns of drugs given to hospitalized patients diagnosed with COVID-19. A total of 1012 participants were recruited in the study. These were identified from the reported positive cases by polymerase chain reaction or antigen reactivity performed in Ulaanbaatar. Result: A total of 1096 patients participated in this study. The mean age was 51.86 ± 16.98 for male patients and 52.23 ± 16.4 for female patients. It has been revealed that there are statistically significant differences between male and female patients. RBC was 4.56 ± 0.79 M/ UL and 5.08 ± 1.36 M/UL, men and women respectively. The levels of C-reactive protein (CRP) in female COVID-19 patients were significantly higher (46.75 ± 72.83 mg/dL) compared to male patients (33.94 ± 47.96 mg/dL). The platelet count (PLT) was 245.32 ± 77.71 for male patients, while there was a significant reduction in PLT count in female patients (229.30 ± 71.59). Conclusions: Patients with COVID-19 in Mongolia appeared to remain in the hospital for 6.86 ± 2.43 days, shorter than in other countries. Hematological analysis showed that female patients had elevated C-reactive protein levels and decreased PLT count.
